Correlation Between Cullinan Oncology and Arcus Biosciences

Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Arcus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Arcus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cullinan Oncology LLC and Arcus Biosciences, you can compare the effects of market volatilities on Cullinan Oncology and Arcus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Arcus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Arcus Biosciences.

Diversification Opportunities for Cullinan Oncology and Arcus Biosciences

0.52

Correlation Coefficient

Cullinan Oncology  Arcus Biosciences

Very weak diversification

The 3 months correlation between Cullinan and Arcus is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Arcus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcus Biosciences and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Arcus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcus Biosciences has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Arcus Biosciences go up and down completely randomly.

Pair Corralation between Cullinan Oncology and Arcus Biosciences

Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the Arcus Biosciences. In addition to that, Cullinan Oncology is 1.01 times more volatile than Arcus Biosciences. It trades about -0.12 of its total potential returns per unit of risk. Arcus Biosciences is currently generating about -0.01 per unit of volatility. If you would invest  1,657  in Arcus Biosciences on September 3, 2024 and sell it today you would lose (113.00) from holding Arcus Biosciences or give up 6.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cullinan Oncology LLC  vs.  Arcus Biosciences

Cullinan Oncology LLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Arcus Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Arcus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Arcus Biosciences is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Cullinan Oncology and Arcus Biosciences

The main advantage of trading using opposite Cullinan Oncology and Arcus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Arcus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcus Biosciences will offset losses from the drop in Arcus Biosciences' long position.

The idea behind Cullinan Oncology LLC and Arcus Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.